Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien R Sutton

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Blood|January 26, 2022
Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1Daniela Castiblanco, Jesse A Rudd-Schmidt, Tahereh Noori, et al.
Plos Pathogens|December 16, 2014
A natural genetic variant of granzyme B confers lethality to a common viral infectionChristopher E Andoniou, Vivien R Sutton, Matthew E Wikstrom, et al.
ACS Pharmacology & Translational Science|June 17, 2022
Preclinical Activity and Pharmacokinetic/Pharmacodynamic Relationship for a Series of Novel Benzenesulfonamide Perforin InhibitorsKate H Gartlan, Jagdish K Jaiswal, Matthew R Bull, et al.
Science Advances|September 14, 2022
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restrictionKenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, et al.
Cancer Immunology Research|May 24, 2020
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the InflammasomeMelody Cheong, Kate H Gartlan, Jason S Lee, et al.
Cell Reports|December 20, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunityTirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Blood|January 26, 2022
Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1Daniela Castiblanco, Jesse A Rudd-Schmidt, Tahereh Noori, et al.
Plos Pathogens|December 16, 2014
A natural genetic variant of granzyme B confers lethality to a common viral infectionChristopher E Andoniou, Vivien R Sutton, Matthew E Wikstrom, et al.
ACS Pharmacology & Translational Science|June 17, 2022
Preclinical Activity and Pharmacokinetic/Pharmacodynamic Relationship for a Series of Novel Benzenesulfonamide Perforin InhibitorsKate H Gartlan, Jagdish K Jaiswal, Matthew R Bull, et al.
Science Advances|September 14, 2022
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restrictionKenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, et al.
Cancer Immunology Research|May 24, 2020
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the InflammasomeMelody Cheong, Kate H Gartlan, Jason S Lee, et al.
Cell Reports|December 20, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunityTirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, et al.
Pageof 4